Development of Modified Drug Delivery Systems with Metformin Loaded in Mesoporous Silica Matrices: Experimental and Theoretical Designs
Authors:
- Mousa Sha’atMSMousa Sha’at
- Maria IgnatMIMaria Ignat
- Florica DorofteiFDFlorica Doroftei
- Vlad GhizdovatVGVlad Ghizdovat
- Maricel AgopMaricel Agop
- Alexandra Barsan (Bujor)A(Alexandra Barsan (Bujor)
- Monica Stamate CretanMCMonica Stamate Cretan
- Fawzia Sha’atFSFawzia Sha’at
- Ramona-Daniela PavaloiuRPRamona-Daniela Pavaloiu
- Adrian Florin SpacASAdrian Florin Spac
- Lacramioara OchiuzLacramioara Ochiuz
- Carmen Nicoleta FilipCFCarmen Nicoleta Filip
Open Access
- 4 July 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (7) , 882
Abstract
Background/Objectives: Mesoporous silica materials, particularly KIT-6, offer promising features, such as large surface area, tunable pore structures, and biocompatibility, making them ideal candidates for advanced drug delivery systems. The aims of this study were to develop and evaluate an innovative modified-release platform for metformin hydrochloride (MTF), using KIT-6 mesoporous silica as a matrix, to enhance oral antidiabetic therapy. Methods: KIT-6 was synthesized using an ultrasound-assisted sol-gel method and subsequently loaded with MTF via adsorption from alkaline aqueous solutions at two concentrations (1 and 3 mg/mL). The structural and morphological characteristics of the matrices—before and after drug loading—were assessed using SEM-EDX, TEM, and nitrogen adsorption–desorption isotherms (the BET method). In vitro drug release profiles were recorded in simulated gastric and intestinal fluids over 12 h. Kinetic modeling was performed using seven classical models, and a multifractal theoretical framework was used to further interpret the complex release behavior. Results: The loading efficiency increased with increasing drug concentration but nonlinearly, reaching 56.43 mg/g for 1 mg/mL and 131.69 mg/g for 3 mg/mL. BET analysis confirmed significant reductions in the surface area and pore volume upon MTF incorporation. In vitro dissolution showed a biphasic release: a fast initial phase in an acidic medium followed by sustained release at a neutral pH. The Korsmeyer–Peppas and Weibull models best described the release profiles, indicating a predominantly diffusion-controlled mechanism. The multifractal model supported the experimental findings, capturing nonlinear dynamics, memory effects, and soliton-like transport behavior across resolution scales. Conclusions: The study confirms the potential of KIT-6 as a reliable and efficient carrier for the modified oral delivery of metformin. The combination of experimental and multifractal modeling provides a deeper understanding of drug release mechanisms in mesoporous systems and offers a predictive tool for future drug delivery design. This integrated approach can be extended to other active pharmaceutical ingredients with complex release requirements.Keywords
Funding Information
- “Grigore T. Popa” University of Medicine and Pharmacy (1756/30.10.2018)
This publication has 33 references indexed in Scilit:
- Advances in mesoporous silica nanoparticles as carriers for drug delivery and other biomedical applicationsMicroporous and Mesoporous Materials, 2025
- An Investigation of the Characterization and Drug Delivery Potential of Ibuprofen Using Modified High Surface Area Porous MaterialsSilicon, 2025
- Mesoporous silica nanoparticles: A Synthesis Guide and Research Progress in the Biomedical FieldMaterials Today Chemistry, 2024
- Comprehensive Review of Mesoporous Silica Nanoparticles: Drug Loading, Release, and Applications as Hemostatic AgentsChemistrySelect, 2024
- Multifunctional mesoporous silica nanoparticles for biomedical applicationsSignal Transduction and Targeted Therapy, 2023
- Biomedical applications of mesoporous silica nanoparticles as a drug delivery carrierJournal of Drug Delivery Science and Technology, 2022
- Mesoporous Silica Nanoparticles for Drug DeliveryAdvanced Functional Materials, 2019
- Amine-functionalized mesoporous silica KIT-6 as a controlled release drug delivery carrierMicroporous and Mesoporous Materials, 2016
- DNA-Hybrid-Gated Photothermal Mesoporous Silica Nanoparticles for NIR-Responsive and Aptamer-Targeted Drug DeliveryACS Applied Materials & Interfaces, 2015
- On the ubiquitous presence of fractals and fractal concepts in pharmaceutical sciences: A reviewInternational Journal of Pharmaceutics, 2013